A comprehensive review examines how chitosan-based nanoparticles enhance targeted therapeutics, diabetes treatments, and diagnostic biosensors while highlighting ongoing biocompatibility challenges.
RNA modification networks and metabolic reprogramming establish reciprocal circuits that drive hepatocellular carcinoma progression and therapeutic resistance.
A three-day 2026 conference in Houston will examine emerging cancer therapeutics, targeted protein modulation, immunotherapies and artificial intelligence in drug ...
A preclinical Singapore study identified PAI-1 and S100A10 as ascites-associated drivers of peritoneal metastases and found that the PAI-1-targeting nanobody ...
A review maps the neddylation pathway, its non-Cullin substrates and small-molecule inhibitors, including two NAE inhibitors that have entered clinical ...
Recent advances in cancer research have unveiled promising therapeutic strategies, particularly in addressing complex malignancies such as anaplastic large cell ...
In the realm of cancer research, a pivotal study has shed light on the role of mixed lineage kinase (MLK) ...
In the rapidly evolving field of oncology, one molecule is emerging as a pivotal player in the intricate balance of ...
The intricate dance of telomeres — the protective caps at the ends of chromosomes — plays a pivotal role in ...
In an exciting advancement for cancer therapeutics and cellular stress biology, a groundbreaking study has unveiled how WEE1 inhibitors activate ...
Transcription is a vital cellular process orchestrated by RNA polymerase II (Pol II), enabling the expression of genes that drive ...
Sir2, a member of the sirtuin family of enzymes, has garnered significant attention due to its pivotal role in various ...
In the ever-evolving landscape of cancer biology, recent discoveries continue to unravel the complex molecular circuits driving tumor development and ...
